Chemotherapy in Ewing's sarcomaThe Scandinavian Sarcoma Group experience
Open Access
- 1 January 2004
- journal article
- review article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 75 (sup311), 87-91
- https://doi.org/10.1080/00016470410001708370
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pilot trial of tumor‐specific peptide vaccination and continuous infusion interleukin‐2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: An inter‐institute NIH study†Medical and Pediatric Oncology, 2002
- High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve PrognosisJournal of Clinical Oncology, 2001
- Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study GroupJournal of Clinical Oncology, 2000
- Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.Journal of Clinical Oncology, 1993